SlideShare a Scribd company logo
Koriesh, Oct 2015
The new oral anticoagulant drugs (NOADs)
Warfarin Dabigatran Rivaroxaban Apixaban Edoxaban
Brand name Coumadin Pradaxa Xarelto Eliquis Savaysa
FDA approval for stroke Before Christ Oct 2010 Nov 2011 Dec 2012 Jan 2015
Dose
Normal individual
Hepatic disease
Kidney disease
Variable
Avoid in Child-P B & C*
No adjustment
150mg BID
Avoid in Child-P B & C*
CrCl 15:30: 75mg BID
20mg Daily(with evening meal)
Avoid in Child-P B & C*
CrCl 15:50: 15mg Daily
5mg BID
Avoid in Child-P B & C*
2.5 BID if 2 of the following
(age>80, Cr >1.5, Wt <60Kg)
60mg Daily
Avoid in Child-P B & C*
CrCl 15:50: 30mg Daily
Costs (monthly) 8$ (5mg) 357$ 357$ 357$ 300$
Reversal Vitamin K Praxiband None None None
Detailed information
Target Vit K factors Factor II Factor Xa Factor Xa Factor Xa
Time to peak 3-5 days 1h 3h 3h 1h
Half life 40h 12h 7-11h 12h 9-11h
Withholding before
procedures
5 days 24h for minor surgery
48h for major surgery
24h for minor surgery
48h for major surgery
24h for minor surgery
48h for major surgery
Interaction Multiple P-glycoprotein
inhibitors**
CYP 3A4 inhibitors & P-
glycoprotein inhibitors**
CYP 3A4 inhibitors & P-
glycoprotein inhibitors**
CYP 3A4 inhibitors & P-
glycoprotein inhibitors**
Renal clearance 0 80% 35% 25% 40%
Compared to warfarin:
Risk of Stroke (RRR)
Risk of ICH (RR)
Risk of GI bleed (RR)
↓ (34%)
↓ (0.4)
↑ (1.5)
Non-inferior
↓
↓
↓ (20%)
↓
↓
Involved Trials RE-LY
RELY-ABLE
ROCKET-AF
Japanese AF
AVERROES
ARISTOTLE
ENGAGE AF-TIMI
*
avoid in Child Pugh B & C due to increased risk of hemorrhage
**
P-glycoprotein inhibitors: include verapamil – Amiodarone – Clarithromycin
- Costs based on prices on 10/30/15 with no coupons or discounts.

More Related Content

What's hot

Formas de apresentaçao dos medicamentos.pdf
Formas de apresentaçao dos medicamentos.pdfFormas de apresentaçao dos medicamentos.pdf
Formas de apresentaçao dos medicamentos.pdf
JulianaNogueira339547
 
GLP-1 RA and Cardiovascular Outcomes
GLP-1 RA and Cardiovascular OutcomesGLP-1 RA and Cardiovascular Outcomes
GLP-1 RA and Cardiovascular Outcomes
Sachpreet Bajaj
 
medicamentos cardiovasculares
medicamentos cardiovascularesmedicamentos cardiovasculares
medicamentos cardiovasculares
Leonardo Souza
 
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASSTIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
CRISTOBAL MORALES PORTILLO
 
Projeto Piloto de Cuidado Farmacêutica na Atenção Básica em Curitiba- Aprese...
Projeto Piloto de Cuidado  Farmacêutica na Atenção Básica em Curitiba- Aprese...Projeto Piloto de Cuidado  Farmacêutica na Atenção Básica em Curitiba- Aprese...
Projeto Piloto de Cuidado Farmacêutica na Atenção Básica em Curitiba- Aprese...
HorusQualifar
 
Distribuição
DistribuiçãoDistribuição
Distribuição
Raíssa Caldas
 
Rivaroxaban
RivaroxabanRivaroxaban
Rivaroxaban
M Vojdan parast
 
Casos básicos: estudo de problemas relacionados com medicamentos 2003
Casos básicos: estudo de problemas relacionados com medicamentos 2003Casos básicos: estudo de problemas relacionados com medicamentos 2003
Casos básicos: estudo de problemas relacionados com medicamentos 2003
Cassyano Correr
 
THE IMPORTANCE OF 24-HOUR BP CONTROL FOR MANAGING CV RISK by dr hendro
THE IMPORTANCE OF 24-HOUR BP CONTROL          FOR MANAGING CV RISK by dr hendroTHE IMPORTANCE OF 24-HOUR BP CONTROL          FOR MANAGING CV RISK by dr hendro
THE IMPORTANCE OF 24-HOUR BP CONTROL FOR MANAGING CV RISK by dr hendro
Suharti Wairagya
 
Bloqueadores Neuromusculares
Bloqueadores NeuromuscularesBloqueadores Neuromusculares
Bloqueadores Neuromusculares
avpantoja1
 
Review on trials of clopidogrel
Review on trials of clopidogrelReview on trials of clopidogrel
Review on trials of clopidogrel
Dharam Prakash Saran
 
Assistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legal
Assistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legalAssistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legal
Assistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legal
Marcelo Polacow Bisson
 
Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...
Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...
Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...
Cassyano Correr
 
Aula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecao
Aula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecaoAula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecao
Aula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecao
JoaopBerlony
 
2. antiinfla
2. antiinfla2. antiinfla
aula 03 - Débito Cardíaco (1).ppt
aula 03 - Débito Cardíaco (1).pptaula 03 - Débito Cardíaco (1).ppt
aula 03 - Débito Cardíaco (1).ppt
fernandohenrique273145
 
Anti-Diabetics For Cardiac Patients The Proper Selection
Anti-Diabetics For Cardiac Patients The Proper SelectionAnti-Diabetics For Cardiac Patients The Proper Selection
Anti-Diabetics For Cardiac Patients The Proper Selection
magdy elmasry
 
Aula antiinflamatórios
Aula  antiinflamatóriosAula  antiinflamatórios
Aula antiinflamatórios
Renato Santos
 
21277f mo --sepse_grave_e_choque_septico_pediatrico-1
21277f mo --sepse_grave_e_choque_septico_pediatrico-121277f mo --sepse_grave_e_choque_septico_pediatrico-1
21277f mo --sepse_grave_e_choque_septico_pediatrico-1
Reila Silva
 
Dpp4i vs sglt2 inhibitors against the motion
Dpp4i vs sglt2 inhibitors  against the motionDpp4i vs sglt2 inhibitors  against the motion
Dpp4i vs sglt2 inhibitors against the motion
Sujoy Majumdar
 

What's hot (20)

Formas de apresentaçao dos medicamentos.pdf
Formas de apresentaçao dos medicamentos.pdfFormas de apresentaçao dos medicamentos.pdf
Formas de apresentaçao dos medicamentos.pdf
 
GLP-1 RA and Cardiovascular Outcomes
GLP-1 RA and Cardiovascular OutcomesGLP-1 RA and Cardiovascular Outcomes
GLP-1 RA and Cardiovascular Outcomes
 
medicamentos cardiovasculares
medicamentos cardiovascularesmedicamentos cardiovasculares
medicamentos cardiovasculares
 
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASSTIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
 
Projeto Piloto de Cuidado Farmacêutica na Atenção Básica em Curitiba- Aprese...
Projeto Piloto de Cuidado  Farmacêutica na Atenção Básica em Curitiba- Aprese...Projeto Piloto de Cuidado  Farmacêutica na Atenção Básica em Curitiba- Aprese...
Projeto Piloto de Cuidado Farmacêutica na Atenção Básica em Curitiba- Aprese...
 
Distribuição
DistribuiçãoDistribuição
Distribuição
 
Rivaroxaban
RivaroxabanRivaroxaban
Rivaroxaban
 
Casos básicos: estudo de problemas relacionados com medicamentos 2003
Casos básicos: estudo de problemas relacionados com medicamentos 2003Casos básicos: estudo de problemas relacionados com medicamentos 2003
Casos básicos: estudo de problemas relacionados com medicamentos 2003
 
THE IMPORTANCE OF 24-HOUR BP CONTROL FOR MANAGING CV RISK by dr hendro
THE IMPORTANCE OF 24-HOUR BP CONTROL          FOR MANAGING CV RISK by dr hendroTHE IMPORTANCE OF 24-HOUR BP CONTROL          FOR MANAGING CV RISK by dr hendro
THE IMPORTANCE OF 24-HOUR BP CONTROL FOR MANAGING CV RISK by dr hendro
 
Bloqueadores Neuromusculares
Bloqueadores NeuromuscularesBloqueadores Neuromusculares
Bloqueadores Neuromusculares
 
Review on trials of clopidogrel
Review on trials of clopidogrelReview on trials of clopidogrel
Review on trials of clopidogrel
 
Assistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legal
Assistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legalAssistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legal
Assistência e Atenção Farmacêutica - Histórico, Conceitos e embasamento legal
 
Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...
Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...
Efeitos da atenção farmacêutica em pacientes com diabetes tipo 2 em farmácia ...
 
Aula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecao
Aula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecaoAula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecao
Aula 3.2 -_farmacocinetica_-_distribuicao_biotransformacao_excrecao
 
2. antiinfla
2. antiinfla2. antiinfla
2. antiinfla
 
aula 03 - Débito Cardíaco (1).ppt
aula 03 - Débito Cardíaco (1).pptaula 03 - Débito Cardíaco (1).ppt
aula 03 - Débito Cardíaco (1).ppt
 
Anti-Diabetics For Cardiac Patients The Proper Selection
Anti-Diabetics For Cardiac Patients The Proper SelectionAnti-Diabetics For Cardiac Patients The Proper Selection
Anti-Diabetics For Cardiac Patients The Proper Selection
 
Aula antiinflamatórios
Aula  antiinflamatóriosAula  antiinflamatórios
Aula antiinflamatórios
 
21277f mo --sepse_grave_e_choque_septico_pediatrico-1
21277f mo --sepse_grave_e_choque_septico_pediatrico-121277f mo --sepse_grave_e_choque_septico_pediatrico-1
21277f mo --sepse_grave_e_choque_septico_pediatrico-1
 
Dpp4i vs sglt2 inhibitors against the motion
Dpp4i vs sglt2 inhibitors  against the motionDpp4i vs sglt2 inhibitors  against the motion
Dpp4i vs sglt2 inhibitors against the motion
 

Similar to New oral anticoagulants

EAHP
EAHPEAHP
EAHP
EAHPEAHP
263_Dosing-information-in-renal-impairment.pdf
263_Dosing-information-in-renal-impairment.pdf263_Dosing-information-in-renal-impairment.pdf
263_Dosing-information-in-renal-impairment.pdf
TAWFIKABBAD
 
2nd term lectures,_bacilli[1]
2nd term lectures,_bacilli[1]2nd term lectures,_bacilli[1]
2nd term lectures,_bacilli[1]
عادل الحربي
 
cardiologische topics huisartsen
cardiologische topics huisartsencardiologische topics huisartsen
cardiologische topics huisartsen
guyodent
 
Anticoag update sept 2018
Anticoag update sept 2018Anticoag update sept 2018
Antimicrobial renal-dosing-guidelines kakaa
Antimicrobial renal-dosing-guidelines kakaaAntimicrobial renal-dosing-guidelines kakaa
Antimicrobial renal-dosing-guidelines kakaa
Ngocanh Bui
 
Diabetes Mellitus A talk for Jas dental employees
Diabetes Mellitus A talk for Jas dental employeesDiabetes Mellitus A talk for Jas dental employees
Diabetes Mellitus A talk for Jas dental employees
Venkatesh Chittarvu
 

Similar to New oral anticoagulants (8)

EAHP
EAHPEAHP
EAHP
 
EAHP
EAHPEAHP
EAHP
 
263_Dosing-information-in-renal-impairment.pdf
263_Dosing-information-in-renal-impairment.pdf263_Dosing-information-in-renal-impairment.pdf
263_Dosing-information-in-renal-impairment.pdf
 
2nd term lectures,_bacilli[1]
2nd term lectures,_bacilli[1]2nd term lectures,_bacilli[1]
2nd term lectures,_bacilli[1]
 
cardiologische topics huisartsen
cardiologische topics huisartsencardiologische topics huisartsen
cardiologische topics huisartsen
 
Anticoag update sept 2018
Anticoag update sept 2018Anticoag update sept 2018
Anticoag update sept 2018
 
Antimicrobial renal-dosing-guidelines kakaa
Antimicrobial renal-dosing-guidelines kakaaAntimicrobial renal-dosing-guidelines kakaa
Antimicrobial renal-dosing-guidelines kakaa
 
Diabetes Mellitus A talk for Jas dental employees
Diabetes Mellitus A talk for Jas dental employeesDiabetes Mellitus A talk for Jas dental employees
Diabetes Mellitus A talk for Jas dental employees
 

More from Ahmed Koriesh

Motor system examination
Motor system examinationMotor system examination
Motor system examination
Ahmed Koriesh
 
Management of advanced parkinson’s disease
Management of advanced parkinson’s diseaseManagement of advanced parkinson’s disease
Management of advanced parkinson’s disease
Ahmed Koriesh
 
Higher visual dysfunction
Higher visual dysfunctionHigher visual dysfunction
Higher visual dysfunction
Ahmed Koriesh
 
Facial nerve anatomy, pathology
Facial nerve anatomy, pathologyFacial nerve anatomy, pathology
Facial nerve anatomy, pathology
Ahmed Koriesh
 
Stroke guidelines
Stroke guidelinesStroke guidelines
Stroke guidelines
Ahmed Koriesh
 
Storage disease
Storage diseaseStorage disease
Storage disease
Ahmed Koriesh
 
Leukodystrophies
LeukodystrophiesLeukodystrophies
Leukodystrophies
Ahmed Koriesh
 
Neuro opthalmology
Neuro opthalmologyNeuro opthalmology
Neuro opthalmology
Ahmed Koriesh
 
Congenital malformations of the skull
Congenital malformations of the skullCongenital malformations of the skull
Congenital malformations of the skull
Ahmed Koriesh
 
Brain anomalies
Brain anomaliesBrain anomalies
Brain anomalies
Ahmed Koriesh
 
Tcd - Transcranial doppler values
Tcd - Transcranial doppler valuesTcd - Transcranial doppler values
Tcd - Transcranial doppler values
Ahmed Koriesh
 
Rvu systemt - physician fee schedule
Rvu systemt -  physician fee scheduleRvu systemt -  physician fee schedule
Rvu systemt - physician fee schedule
Ahmed Koriesh
 
Antihypertensive
AntihypertensiveAntihypertensive
Antihypertensive
Ahmed Koriesh
 
Vasopressors
VasopressorsVasopressors
Vasopressors
Ahmed Koriesh
 
Anti-Parkinson drugs
Anti-Parkinson drugsAnti-Parkinson drugs
Anti-Parkinson drugs
Ahmed Koriesh
 
Antiepileptic drug doses
Antiepileptic drug dosesAntiepileptic drug doses
Antiepileptic drug doses
Ahmed Koriesh
 
Emperical antibiotics in ICU
Emperical antibiotics in ICUEmperical antibiotics in ICU
Emperical antibiotics in ICU
Ahmed Koriesh
 
Multiple sclerosis disease modifying therapies
Multiple sclerosis disease modifying therapiesMultiple sclerosis disease modifying therapies
Multiple sclerosis disease modifying therapies
Ahmed Koriesh
 
Child Development Milestones
Child Development MilestonesChild Development Milestones
Child Development Milestones
Ahmed Koriesh
 

More from Ahmed Koriesh (19)

Motor system examination
Motor system examinationMotor system examination
Motor system examination
 
Management of advanced parkinson’s disease
Management of advanced parkinson’s diseaseManagement of advanced parkinson’s disease
Management of advanced parkinson’s disease
 
Higher visual dysfunction
Higher visual dysfunctionHigher visual dysfunction
Higher visual dysfunction
 
Facial nerve anatomy, pathology
Facial nerve anatomy, pathologyFacial nerve anatomy, pathology
Facial nerve anatomy, pathology
 
Stroke guidelines
Stroke guidelinesStroke guidelines
Stroke guidelines
 
Storage disease
Storage diseaseStorage disease
Storage disease
 
Leukodystrophies
LeukodystrophiesLeukodystrophies
Leukodystrophies
 
Neuro opthalmology
Neuro opthalmologyNeuro opthalmology
Neuro opthalmology
 
Congenital malformations of the skull
Congenital malformations of the skullCongenital malformations of the skull
Congenital malformations of the skull
 
Brain anomalies
Brain anomaliesBrain anomalies
Brain anomalies
 
Tcd - Transcranial doppler values
Tcd - Transcranial doppler valuesTcd - Transcranial doppler values
Tcd - Transcranial doppler values
 
Rvu systemt - physician fee schedule
Rvu systemt -  physician fee scheduleRvu systemt -  physician fee schedule
Rvu systemt - physician fee schedule
 
Antihypertensive
AntihypertensiveAntihypertensive
Antihypertensive
 
Vasopressors
VasopressorsVasopressors
Vasopressors
 
Anti-Parkinson drugs
Anti-Parkinson drugsAnti-Parkinson drugs
Anti-Parkinson drugs
 
Antiepileptic drug doses
Antiepileptic drug dosesAntiepileptic drug doses
Antiepileptic drug doses
 
Emperical antibiotics in ICU
Emperical antibiotics in ICUEmperical antibiotics in ICU
Emperical antibiotics in ICU
 
Multiple sclerosis disease modifying therapies
Multiple sclerosis disease modifying therapiesMultiple sclerosis disease modifying therapies
Multiple sclerosis disease modifying therapies
 
Child Development Milestones
Child Development MilestonesChild Development Milestones
Child Development Milestones
 

Recently uploaded

SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 

Recently uploaded (20)

SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 

New oral anticoagulants

  • 1. Koriesh, Oct 2015 The new oral anticoagulant drugs (NOADs) Warfarin Dabigatran Rivaroxaban Apixaban Edoxaban Brand name Coumadin Pradaxa Xarelto Eliquis Savaysa FDA approval for stroke Before Christ Oct 2010 Nov 2011 Dec 2012 Jan 2015 Dose Normal individual Hepatic disease Kidney disease Variable Avoid in Child-P B & C* No adjustment 150mg BID Avoid in Child-P B & C* CrCl 15:30: 75mg BID 20mg Daily(with evening meal) Avoid in Child-P B & C* CrCl 15:50: 15mg Daily 5mg BID Avoid in Child-P B & C* 2.5 BID if 2 of the following (age>80, Cr >1.5, Wt <60Kg) 60mg Daily Avoid in Child-P B & C* CrCl 15:50: 30mg Daily Costs (monthly) 8$ (5mg) 357$ 357$ 357$ 300$ Reversal Vitamin K Praxiband None None None Detailed information Target Vit K factors Factor II Factor Xa Factor Xa Factor Xa Time to peak 3-5 days 1h 3h 3h 1h Half life 40h 12h 7-11h 12h 9-11h Withholding before procedures 5 days 24h for minor surgery 48h for major surgery 24h for minor surgery 48h for major surgery 24h for minor surgery 48h for major surgery Interaction Multiple P-glycoprotein inhibitors** CYP 3A4 inhibitors & P- glycoprotein inhibitors** CYP 3A4 inhibitors & P- glycoprotein inhibitors** CYP 3A4 inhibitors & P- glycoprotein inhibitors** Renal clearance 0 80% 35% 25% 40% Compared to warfarin: Risk of Stroke (RRR) Risk of ICH (RR) Risk of GI bleed (RR) ↓ (34%) ↓ (0.4) ↑ (1.5) Non-inferior ↓ ↓ ↓ (20%) ↓ ↓ Involved Trials RE-LY RELY-ABLE ROCKET-AF Japanese AF AVERROES ARISTOTLE ENGAGE AF-TIMI * avoid in Child Pugh B & C due to increased risk of hemorrhage ** P-glycoprotein inhibitors: include verapamil – Amiodarone – Clarithromycin - Costs based on prices on 10/30/15 with no coupons or discounts.